Top 1% of Inpatients Administered Antimicrobial Agents Comprising 50% of Expenditures: A Descriptive Study and Opportunities for Stewardship Intervention

Abstract

OBJECTIVE To characterize the top 1% of inpatients who contributed to the 6-month antimicrobial budget in a tertiary, academic medical center and identify cost-effective intervention opportunities targeting high-cost antimicrobial utilization. DESIGN Retrospective cohort study. PATIENTS Top 1% of the antimicrobial budget from July 1 through December 31, 2014. METHODS Patients were identified through a pharmacy billing database. Baseline characteristics were collected through a retrospective medical chart review. Patients were presented to the antimicrobial stewardship team to determine appropriate utilization of high-cost antimicrobials and potential intervention opportunities. Appropriate use was defined as antimicrobial therapy that was effective, safe, and most cost-effective compared with alternative agents. RESULTS A total of 10,460 patients received antimicrobials in 6 months; 106 patients accounted for $889,543 (47.2%) of the antimicrobial budget with an antimicrobial cost per day of $219±$192 and antimicrobial cost per admission of $4,733±$7,614. Most patients were immunocompromised (75%) and were followed by the infectious disease consult service (80%). The most commonly prescribed antimicrobials for treatment were daptomycin, micafungin, liposomal amphotericin B, and meropenem. Posaconazole and valganciclovir accounted for most of the prophylactic therapy. Cost-effective opportunities (n=71) were present in 57 (54%) of 106 patients, which included dose optimization, de-escalation, dosage form conversion, and improvement in transitions of care. CONCLUSION Antimicrobial stewardship oversight is important in implementing cost-effective strategies, especially in complex and immunocompromised patients who require the use of high-cost antimicrobials. Infect Control Hosp Epidemiol 2017;38:259-265.

Evaluation of fidaxomicin use in community hospitals after a clinical guideline change at a large health system and opportunities for stewardship

“…7 One study demonstrated that 80% of patients in an acute-care hospital accounting for the top 1% of drug expenditures were followed by ID consulting services, and more than half of these had opportunities for cost-effective stewardship interventions. 9 Antimicrobial stewardship programs should collaborate with ID consultants in coordinating optimal, cost-effective, and guideline-adherent pharmacotherapy.…”

Peer Comparison of Anti-MRSA Agent Prescription in the Inpatient Setting

“…Curbing the use of anti-MRSA agents in the hospital is of interest due to resistance, toxicity, and cost concerns, and daptomycin is a particular target. [6][7][8] As part of a new Joint Commission Standard, antimicrobial stewardship programs and hospitals are required to track antibiotic prescription, to implement prescriber education, and to report antibiotic utilization data back to the prescribers. 9 Therefore, a reliable measure for tracking and reporting is important.…”

Examining Antimicrobial Stewardship Program Implementation in Carceral Settings

“…They may also offer the potential to provide higher-quality, more costeffective care to vulnerable patients, similar to ASP programs in other health care settings. 37,38 Implementation of ASPs in jails and prisons, however, is a short-term solution to help improve the conditions of confinement. In parallel, we support legislative and policy reforms that seek to address and reverse the harms of incarceration.…”